Nigeria

Resilience System


You are here

Government

U.S. Health Officials Question AstraZeneca Vaccine Trial Results

Federal health officials said early Tuesday that results from a U.S. trial of AstraZeneca’s Covid-19 vaccine may have relied on “outdated information” that “may have provided an incomplete view of the efficacy data,” casting doubt on an announcement on Monday that had been seen as good news for the British-Swedish company as well as the global vaccination drive.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OPINION: How can we get people to trust the AstraZeneca and other vaccines?

News Update: A U.S. trial found that AstraZeneca’s vaccine was 79 percent effective with no serious side effects, according to results released on Monday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: How Europe Went Wrong in Its Vaccine Rollout

BRUSSELS — The calls began in December, as the United States prepared to administer its first batches of Covid-19 vaccine. Even then, it was clear that the European Union was a few weeks behind, and its leaders wanted to know what they could learn from their American counterparts.

The questions were the same, from President Emmanuel Macron of France, President Ursula von der Leyen of the European Commission, and Alexander De Croo, the prime minister of Belgium.

“How did you do it?” Dr. Moncef Slaoui, the United States vaccine czar, recalled them asking on the calls. “And what do you think we missed?”

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Overview of Covid-19 cases rising in much of the world--the Economist, with graphs

LIKE A STORY-BOOK villain, the covid-19 pandemic has a habit of fighting back from the brink of defeat. Last summer politicians were quick to assume that the coronavirus had been squashed, only for a second wave to engulf much of Europe and North America in the autumn.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Government
howdy folks
Page loaded in 1.268 seconds.